JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB258970

Human MPV17 knockout HeLa cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

MPV17 KO cell lysate available now. KO validated by. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon4.

View Alternative Names

Glomerulosclerosis, MPV17_HUMAN, MTDPS6, MpV17 mitochondrial inner membrane protein, Mpv17 human homolog of glomerulosclerosis and nephrotic syndrome, Protein Mpv17, SYM1

1 Images
Sanger Sequencing - Human MPV17 knockout HeLa cell lysate (AB258970)
  • Sanger seq

Unknown

Sanger Sequencing - Human MPV17 knockout HeLa cell lysate (AB258970)

Homozygous : 1 bp deletion in exon4

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon4.

Disease

Adenocarcinoma

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab258970-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human MPV17 knockout HeLa cell lysate", "number":"AB258970-CMP01", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HeLa cell lysate", "number":"AB258970-CMP02", "productcode":"" } ] } } }

Properties and storage information

Gene name
MPV17
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

MPV17 also known as MPV17 mitochondrial inner membrane protein plays an important role in the integrity of mitochondrial DNA (mtDNA) maintenance. It is a 20 kDa protein found primarily in the inner mitochondrial membrane. Expression of MPV17 occurs in various tissues notably in the liver kidney and central nervous system. The protein localizes to mitochondria where it is involved in maintaining mitochondrial function.
Biological function summary

MPV17 affects several processes related to cellular energy production. It is part of a larger protein family involved in mitochondrial homeostasis. MPV17 contributes to the regulation of oxidative phosphorylation by modulating mitochondrial DNA content. This regulation assures proper function of the respiratory chain complexes required for cellular energy provision. Additionally its activity helps prevent mtDNA damage that may arise from oxidative stress.

Pathways

MPV17 influences energy metabolism pathways critical for cell viability. It interacts with the mitochondrial DNA maintenance pathway facilitating the replication and distribution of mtDNA within cells. MPV17 has functional associations with other proteins like POLG which is the catalytic subunit of the mitochondrial DNA polymerase responsible for replication and repair. This relationship ensures the stability and transcription of mitochondrial genome necessary for proper cellular energy management.

Mutations in MPV17 lead to conditions like mitochondrial DNA depletion syndrome (MDDS) and Navajo neurohepatopathy. MDDS results in reduced mtDNA levels affecting energy production and leading to severe liver and neurological disorders. The disease links MPV17 to other proteins involved in mitochondrial maintenance such as TWNK another protein necessary for mtDNA maintenance and expression. Understanding MPV17’s role in these pathologies can provide insights into potential therapeutic strategies for corresponding mitochondrial disorders.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com